Abstract
Several different classes of compounds enhance the potency of aminergic receptor ligands three-fold or more and increase their duration of activity up to ten-fold. These enhancers include the vitamins ascorbic acid and folic acid, chelators such as ethylenediaminetetraacetic acid, corticosteroids, and opioids, opiates and opiate antagonists. We have previously demonstrated that all of these classes of enhancers share a common molecular motif consisting of a linear array of two hydroxyls and a carbonyl. We demonstrate here that because of this common molecular motif, all compounds known to enhance aminergic receptor ligands bind to highly conserved regions of the first or second extracellular loops of aminergic receptors at physiologically or pharmacologically relevant concentrations. These compounds also bind directly to aminergic ligands with significant specificity and affinity. These results suggest three very simple, complementary methods for screening for novel extracellular aminergic receptor enhancers: 1) in silico screening for the presence of the common aminergic receptor enhancer motif; 2) screening for binding to the aminergic ligand of choice; and 3) screening for binding to receptor peptides representing the enhancer binding site on the receptor. Using these three complementary methods, we predict a new class of enhancers (tartaric acids) and demonstrate the predicted enhancement in an in vitro smooth muscle assay.
Keywords: Ascorbate, enhancers, epinephrine, fade, norepinephrine, tachyphylaxis, tartrate.
Current Drug Discovery Technologies
Title:Tartaric Acid Enhances Adrenergic Receptor Activity: Test of a General Theory of Extracellular Aminergic GPCR Enhancer Discovery
Volume: 11 Issue: 4
Author(s): Robert Root-Bernstein, Jenna Fewins and Patrick F. Dillon
Affiliation:
Keywords: Ascorbate, enhancers, epinephrine, fade, norepinephrine, tachyphylaxis, tartrate.
Abstract: Several different classes of compounds enhance the potency of aminergic receptor ligands three-fold or more and increase their duration of activity up to ten-fold. These enhancers include the vitamins ascorbic acid and folic acid, chelators such as ethylenediaminetetraacetic acid, corticosteroids, and opioids, opiates and opiate antagonists. We have previously demonstrated that all of these classes of enhancers share a common molecular motif consisting of a linear array of two hydroxyls and a carbonyl. We demonstrate here that because of this common molecular motif, all compounds known to enhance aminergic receptor ligands bind to highly conserved regions of the first or second extracellular loops of aminergic receptors at physiologically or pharmacologically relevant concentrations. These compounds also bind directly to aminergic ligands with significant specificity and affinity. These results suggest three very simple, complementary methods for screening for novel extracellular aminergic receptor enhancers: 1) in silico screening for the presence of the common aminergic receptor enhancer motif; 2) screening for binding to the aminergic ligand of choice; and 3) screening for binding to receptor peptides representing the enhancer binding site on the receptor. Using these three complementary methods, we predict a new class of enhancers (tartaric acids) and demonstrate the predicted enhancement in an in vitro smooth muscle assay.
Export Options
About this article
Cite this article as:
Root-Bernstein Robert, Fewins Jenna and F. Dillon Patrick, Tartaric Acid Enhances Adrenergic Receptor Activity: Test of a General Theory of Extracellular Aminergic GPCR Enhancer Discovery, Current Drug Discovery Technologies 2014; 11 (4) . https://dx.doi.org/10.2174/157016381104150507121846
DOI https://dx.doi.org/10.2174/157016381104150507121846 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Physical Activity and Hypertension: Evidence of Cross-Sectional Studies,Cohort Studies and Meta-Analysis
Current Hypertension Reviews Pharmacogenetics of Antihypertensive Therapies: Can this be Applied in the Clinic?
Current Pharmacogenomics and Personalized Medicine Investigations into the Inhibition of Luminol Chemiluminescence by some Novel Metal Complexes
Current Analytical Chemistry Natural Polyphenols in the Treatment of Alzheimer’s Disease
Current Drug Targets Editorial [Hot Topic Management of Perioperative Systemic Inflammation During Cardiopulmonary Bypass: We Need a Multimodal Approach (Guest Editor: David Faraoni)]
Recent Patents on Cardiovascular Drug Discovery Reactions of 4-(Diethylamino)selenet-2(2H)-imine with Nucleophiles – Synthesis of 2-Methylen-3-oxobutane Selenoamides
Letters in Organic Chemistry Malignant Hypertension: A Rare Problem or is it Underdiagnosed?
Current Vascular Pharmacology Inflamm-ageing and senescence in gout: the tale of an old king’s disease.
Current Aging Science Early Vascular Ageing (EVA): Definitions and Clinical Applicability
Current Hypertension Reviews Metabolic Syndrome: Clinical Features Leading to Therapeutic Strategies
Vascular Disease Prevention (Discontinued) Small Molecule Complementarity As A Source of Novel Pharmaceutical Agents and Combination Therapies
Current Pharmaceutical Design Symptoms in Dilating Venous Disease
Current Cardiology Reviews Alzheimer Biomarkers and Clinical Alzheimer Disease were Not Associated with Increased Cerebrovascular Disease in a Memory Clinic Population
Current Alzheimer Research Common Therapeutic Strategies in the Management of Sexual Dysfunction and Cardiovascular Disease
Current Drug Targets - Cardiovascular & Hematological Disorders Aqueous Extract of <i>Cola nitida</i> and <i>Garcinia kola</i> Synergistically Enhances Hippocampal-hypothalamic Glutamate and Na+ /K+ -ATPase Activity in Male Wistar Rats
Current Drug Discovery Technologies The Relationship Between Prolidase Activity and Atrial Electromechanical Changes in Patients with Paroxysmal Atrial Fibrillation
Combinatorial Chemistry & High Throughput Screening Editorial [Hot Topic:Modifying Cardiovascular Risk Factors: Newer Insights and Preventive Measures (Executive Editor: Aurelio Leone)]
Current Pharmaceutical Design Aging and DNA Methylation
Current Chemical Biology Editorial [ Hot Topic: The Blood-Brain Barrier as a Cause of Disease (Executive Editor: William A. Banks) ]
Current Pharmaceutical Design Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress
Current Neuropharmacology